Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,118 total articles
Occidental (OXY) is trading well below its 52-week high after a big rebound earlier in 2026. With free cash flow of roughly $4.1B, a manageable debt-to-equity ratio near 0.62, and oil prices still elevated, a confirmed CEO transition that prioritizes buybacks and capital returns could re-rate the stock. This trade idea proposes a mid-term long with…
Klaviyo has been hammered in recent sessions, trading down to $15.81 after a rush of short activity and panic selling. The core business - a data-driven ecommerce marketing platform with strong free cash flow and healthy liquidity - still argues for upside. This is a swing trade: buy the panic, size it appropriately, and manage risk with a strict s…
PayPal is trading at roughly 9x earnings and generating over $5.5B in free cash flow while the market focuses on near-term margin pain and competition. That pessimism looks priced in. This trade idea lays out a mid-term swing long with entry, stop and target, plus catalysts and risks to monitor.
Meta is pulling back from recent highs, but fundamentals still support owning the stock. Strong free cash flow ($48.25B), healthy ROE (29%), and a reasonable P/E (~22x) coupled with continued ad and data-center-driven AI demand make a mid-term long trade attractive. Enter near $610 with a tight stop and a two-stage target plan tied to a recovery in…
PayPal is trading at a compelling multiple after a difficult run; the company still generates strong free cash flow, benefits from Venmo and BNPL tailwinds, and trades below previous valuation highs. We lay out a mid-term trade: enter on weakness, cap risk with a clear stop, and target a recovery toward healthier multiples if fundamentals reacceler…
Neurocrine (NBIX) is a high-quality cash-flowing biotech with a $14.8B market cap, durable Ingrezza royalties and a growing pipeline. The April Soleno deal introduces a binary upside via Vykat XR but adds near-term execution and integration risk. We favor a tactical long over the next 45 trading days with a clear entry, stop and target.
Blue Owl (OWL) is trading well below intrinsic cash-flow metrics while still paying an ~8% yield. Redemption noise and private credit headlines have pushed the stock into bargain territory. This trade buys the fear, uses a tight stop, and targets a recovery driven by cash flow stability, dividend support, and a re-rating if redemption pressures pro…
PayPal is trading well below prior highs but still generates strong free cash flow and benefits from faster-growing Venmo and BNPL volumes. Valuation looks attractive on P/E, EV/EBITDA and free-cash-flow metrics. This trade idea favors a measured long with a defined entry, stop and target over a 180-trading-day horizon while acknowledging execution…
Liberty Global (LBTYA) trades cheaply on headline multiples ($12.29) with a $4.24B market cap and an EV of ~$10.65B. Recent AI partnership, Liberty Blume progress, and ongoing asset moves create a realistic path to a re-rate. This trade sets a clear entry at $12.30, a stop at $10.50, and a mid-term target of $15.00 (45 trading days) to capture near…
Mobileye's Q1 picture is mixed on headline GAAP noise but strengthened by China OEM demand, a $250M buyback and durable ADAS traction. The trade is a tactical long into mid-term catalysts with a clear stop to limit downside if legacy concerns re-emerge.
Jazz Pharmaceuticals' positive Phase 3 Ziihera results have transformed its growth trajectory. The market has reacted, but Jazz still offers a compelling risk/reward: $14.6B market cap, $1.297B free cash flow and an EV/EBITDA of 13.7 imply room for multiple expansion if commercial rollouts and approvals proceed. This trade recommends a long with cl…
BioMarin (BMRN) is a Strong Buy on a concrete catalyst set: expanding demand for VOXZOGO in skeletal dysplasia and a value-accretive acquisition of Amicus. The balance sheet, free cash flow and a modest valuation frame a favorable risk/reward. Trade plan: enter $54.60, target $68.00, stop $49.00, horizon mid term (45 trading days).
Acme United (ACU) has climbed off its 2025 lows but remains attractively valued relative to its free cash flow, EV/EBITDA and low leverage. The recent My Medic acquisition and consistently paid quarterly dividends create a lower-risk entry for a position trade. We lay out an actionable entry, stop and target with time-based rationale.
Super Micro's Q3 results and forward guidance point to a material margin recovery driven by AI GPU server demand. The stock has rallied hard, but fundamentals plus technical momentum support a defined long swing trade: entry $34.25, stop $28.00, target $46.00 over roughly 45 trading days.
Salesforce (CRM) has been punished with the broader software sell-off, but fundamentals and AI optionality argue against a terminal 'SaaSpocalypse.' With $14.4B in free cash flow, a conservative capital structure and trading well below last year's highs, CRM offers a risk-reward edge. This is a trade: enter $183.00, stop $165.00, target $240.00 ove…
Lithium Americas (LAC) looks poised to re-rate as U.S. policy and tightening supply converge on domestic lithium projects. With a market cap near $2.07B, a strong cash buffer on a per-share basis, and constructive technicals, this trade targets a move back toward last year's highs while protecting capital with a clear stop. Catalysts include faster…
Occidental's asset mix, $4.1B of free cash flow and an EV/EBITDA near 7 create a constructive valuation setup if oil prices stay elevated. This trade idea targets a move back toward the 52-week high with defined entry, stop and target levels and a 180 trading-day horizon, while acknowledging macro and company-specific risks.
Lumentum (LITE) trades near $908.88 on a market cap of roughly $64.9B and valuation multiples (P/E ~304, P/S ~32) that assume flawless scaling. Recent headlines and supply/backlog anecdotes point to constrained manufacturing and stretched working capital - an environment that can produce sharp mean reversion. This is a tactical short idea: enter ne…
Nokia’s strategic shift toward higher-margin infrastructure and cloud-native software, combined with strong demand for optical networking to support 5G and AI-driven data growth, provides a clear catalyst. This trade idea lays out a mid-term swing trade that captures momentum while protecting capital with a defined stop.
Diageo (DEO) has been sold down on near-term top-line weakness and industry consolidation stories, but the company's scale, cash generation and valuation create an asymmetric risk-reward. This trade idea outlines a disciplined long with an entry at $84.00, a $75.00 stop and a $100.00 target on a 45-trading-day horizon, driven by improving sentiment…
Berkshire Hathaway is a once-in-a-generation conglomerate with a $1.01T market cap, a deep cash war chest and free cash flow generation that supports opportunistic buying. Recent weakness and a below-peak valuation make incremental buys attractive. This trade idea lays out an entry near $700,000, a conservative stop at the 52-week low, and a target…
Amazon is deploying two capital-intensive engines - AI infrastructure and an open logistics product - that together can re-price a multi-trillion dollar addressable market. The stock trades near $275 with a $2.98T market cap; we argue a disciplined long here captures upside as AWS AI monetization and Amazon Supply Chain Services scale. Risk is real…
Venture Global (VG) is being repriced higher as a structural LNG supply shock and fresh offtake/financing wins make the company a near-term beneficiary. We upgrade the rating to a tactical Buy and propose a clear trade: enter at $12.00, stop at $9.50, target $22.00 over a 180-trading-day horizon, with strict position sizing given leverage and negat…
Peoples Bancorp of North Carolina (PEBK) is trading at roughly 1.3x book and a mid-teens ROE after a steady run of dividends and positive free cash flow. The stock offers a reasonable entry for a patient, defined-risk long trade over the next 180 trading days, with upside from multiple expansion and modest earnings growth while downside is capped b…
Madison Square Garden Sports (MSGS) shows constructive price action backed by rising short interest, a tight float and improving technicals. We lay out an entry at $338.16 with a $355 target and a $322 stop, sized for a mid-term trade (45 trading days) that aims to capture near-term upside while respecting seasonality and valuation risks.
